Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1336 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Minimally Invasive Robot-assisted and Laparoscopic Distal Pancreatectomy in a Pan-European Registry

NCT06160154

Pancreas Disease

COMPLETED

A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers

NCT03172572

Pancreatic Neoplasms Pancreas Cyst Pancreas Cancer

COMPLETED

Evaluation of Postoperative Outcomes and Mortality in Laparoscopic and Robotic Distal Pancreatectomy

NCT07338409

Distal Pancreatectomy (DP)

COMPLETED

Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy

NCT05110573

Pancreatic Neoplasms

COMPLETED

Laparoscopic Pancreatoduodenectomy Versus Open Pancreatoduodenectomy

NCT05520606

Resectable Lesions Located in the Pancreatic Head or Periampullary Region

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe. International multicenter audit-based studies focusing on outcomes of minimally invasive pancreatoduodenectomy (MIPD) are lacking.

A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreas Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

all patients undergoing minimally invasive pancreatic surgery, no intervention, no randomization

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Data from all patients who underwent R-MIPD and L-MIPD between January 1st 2019 and December 31st 2021 were included

Exclusion Criteria

* Other pancreatic procedures
* Hybrid approaches (reconstruction phase open)
* Procedures with insufficient baseline data / missing primary outcome data.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No